Summary: NEO.LIFE takes an interdisciplinary look at the role of psychiatrists as prescribers in the psychedelic field, featuring perspectives from psychiatrists, therapists, researchers, and policy experts.
While therapy and psychopharmacology may be greatly supported by psychedelics in medical contexts, MAPS Director of Policy and Advocacy Ismail L. Ali, J.D., points out that “many people who use psychedelics are not necessarily doing it for the treatment of a specific indication.”
